Psychosocial Characteristics of Women with a Delayed Diagnosis of Turner Syndrome

Gabrielle E Reimann, Martha M Bernad Perman, Pei-Shu Ho, Rebecca A Parks, Leora E Comis, Gabrielle E Reimann, Martha M Bernad Perman, Pei-Shu Ho, Rebecca A Parks, Leora E Comis

Abstract

Objectives: To characterize the psychosocial profiles of adult women diagnosed with Turner syndrome before (early diagnosis) and at or after (late diagnosis) 13 years of age.

Study design: Women with Turner syndrome ages 22 and older at evaluation (n = 110) participated in a cross-sectional study at the National Institutes of Health. Researchers performed nonparametric and logistic regression analyses to assess early and late diagnosis cohorts on measures of depression, substance use, and perceptions of competence and identity.

Results: Of study participants, 47% received a Turner syndrome diagnosis at or after age 13 years. Median age at diagnosis was 12.0 years (range, 0-43). Covariate-adjusted models revealed that women with late diagnoses had an increased likelihood of developing mild to severe depressive symptoms (OR, 7.36) and a decreased likelihood of being perceived as competent (OR, 0.26). Women with a late diagnosis also exhibited more frequent substance use compared with women with early diagnoses.

Conclusions: These data suggest that Turner syndrome diagnoses received at or after age 13 years may contribute to adverse outcomes related to depression, substance use, and perceptions of competence. Delayed Turner syndrome diagnoses may place women and girls at risk for negative psychosocial development extending into adulthood. These findings indicate it is important for pediatricians to evaluate psychosocial domains in girls with Turner syndrome regularly, particularly among those diagnosed at age 13 years or older.

Trial registration: ClinicalTrials.gov: NCT00006334.

Keywords: alcohol; depression; drug; growth hormone; identity; late diagnosis.

Conflict of interest statement

The authors declare no conflicts of interest.

Published by Elsevier Inc.

Source: PubMed

3
Abonneren